The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study.

Autor: Laru, Lauri, Ronkainen, Hanna, Ohtonen, Pasi, Vaarala, Markku H.

Publikováno v: Scandinavian Journal of Surgery; Sep2024, Vol. 113 Issue 3, p219-228, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 3 of Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010

Autor: Laru, Lauri, Ronkainen, Hanna, Ohtonen, Pasi, Vaarala, Markku H.

Additional file 3: Supplemental Figure 1. Survival analyses for different nephrectomy status groups excluding patients who received first-line interferon. Kaplan-meier curves are shown in Supplemental Figure 1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e48b0b355e17b24131625580dbbd6a

Additional file 1 of Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010

Autor: Laru, Lauri, Ronkainen, Hanna, Ohtonen, Pasi, Vaarala, Markku H.

Additional file 1: Supplemental Table 1. Baseline patient characteristics in different nephrectomy status patient groups. 148 patients who received first-line interferon therapy with or without concurrent chemotherapy are not included.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a1845a8bd008a4fb4e4c87024d9a64

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Autor: Kasivisvanathan, Veeru, Rannikko, Antti S, Borghi, Marcelo, Panebianco, Valeria, Mynderse, Lance A, Vaarala, Markku H, Briganti, Alberto, Budäus, Lars, Hellawell, Giles, Hindley, Richard G, Roobol, Monique J, Eggener, Scott, Ghei, Maneesh, Villers, Arnauld, Bladou, Franck, Villeirs, Geert M, Virdi, Jaspal, Boxler, Silvan, Robert, Grégoire, Singh, Paras B, Venderink, Wulphert, Hadaschik, Boris A, Ruffion, Alain, Jim C, Hu, Margolis, Daniel, Crouzet, Sébastien, Klotz, Laurence, Taneja, Samir S, Pinto, Peter, Gill, Inderbir, Allen, Clare, Giganti, Francesco, Freeman, Alex, Morris, Stephen, Punwani, Shonit, Williams, Norman R, Brew-Graves, Chris, Deeks, Jonathan, Takwoingi, Yemisi, Emberton, Mark, Moore, Caroline M, Precision, Study Group Collaborators, Catalano, Carlo, Leonardo, Costantino, Sciarra, Alessandro, Grompone, Marcello Domenico, Del Monte, Maurizio, D'Eramo, Giuseppe, Salvo, Vincenzo, Campa, Riccardo

Publikováno v: The New England Journal of Medicine, 378, 1767-1777
New England Journal of Medicine, 378(19), 1767-1777. Massachussetts Medical Society
The New England Journal of Medicine, 378, 19, pp. 1767-1777

BACKGROUND: Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4426d9ebe526f21d25b3b7b20b76080e
https://pure.eur.nl/en/publications/2f8e39b9-b707-4f55-9186-fcfa9e9673fb